Neurotoxicity of MDMA: main effects and mechanisms

G Costa, K Gołembiowska - Experimental neurology, 2022 - Elsevier
Preclinical and clinical studies indicate that 3, 4-methylenedioxymethamphetamine
(MDMA;'ecstasy'), in addition to having abuse potential, may elicit acute and persistent …

[HTML][HTML] The role of adenosine receptors in psychostimulant addiction

I Ballesteros-Yáñez, CA Castillo, S Merighi… - Frontiers in …, 2018 - frontiersin.org
Adenosine receptors (AR) are a family of G-protein coupled receptors, comprised of four
members, named A 1, A 2A, A 2B, and A 3 receptors, found widely distributed in almost all …

MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults

GM Jones, MK Nock - Journal of psychopharmacology, 2022 - journals.sagepub.com
Background: Suicide is one of the leading causes of death worldwide and rates within the
United States have risen over the past two decades. Hence, there is a critical need for novel …

Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes

GM Jones, MK Nock - Journal of Psychopharmacology, 2022 - journals.sagepub.com
Background: Depression is a major mental health issue worldwide, with high rates of
chronicity and non-recovery associated with the condition. Existing treatments such as …

[HTML][HTML] Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice

G Costa, M Serra, R Maccioni, MA Casu… - Biomedicine & …, 2023 - Elsevier
Withania somnifera (WS) is utilized in Ayurvedic medicine owing to its central and peripheral
beneficial properties. Several studies have accrued indicating that the recreational …

3, 4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats

HS Hake, JKP Davis, RR Wood, MK Tanner… - Physiology & …, 2019 - Elsevier
Clinical trials have demonstrated that 3, 4-methylenedioxymethamphetamine (MDMA)
paired with psychotherapy is more effective at reducing symptoms of post-traumatic stress …

Novel psychoactive phenethylamines: impact on genetic material

V Cocchi, S Gasperini, P Hrelia, M Tirri, M Marti… - International Journal of …, 2020 - mdpi.com
Psychedelic and stimulating phenethylamines belong to the family of new psychoactive
substances (NPS). The acute toxicity framework has begun to be investigated, while studies …

Stimulant and hallucinogenic novel psychoactive substances; an update

F Schifano, A Vento, N Scherbaum… - Expert Review of …, 2023 - Taylor & Francis
Introduction The renewed interest in considering a range of stimulants, psychedelics and
dissociatives as therapeutics emphasizes the need to draft an updated overview of these …

Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway

J Renaud, V Bassareo, J Beaulieu, A Pinna… - Neurobiology of …, 2018 - Elsevier
Epidemiological evidence suggests a correlation between diabetes and age-related
neurodegenerative disorders, including Alzheimer's and Parkinson's diseases …

Neurochemical and behavioral effects of a new hallucinogenic compound 25B-NBOMe in rats

A Wojtas, M Herian, M Skawski, M Sobocińska… - Neurotoxicity …, 2021 - Springer
Bromo-2, 5-dimethoxy-N-(2-methoxybenzyl) phenethylamine (25B-NBOMe) is a
hallucinogen exhibiting high binding affinity for 5-HT 2A/C serotonin receptors. In the …